Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Surabhi Palkimas

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|September 23, 2021
Safety and Efficacy of Direct Oral Anticoagulants in Patients With Moderate to Severe CirrhosisMildred Oldham, Surabhi Palkimas, Amanda Hedrick
Journal of Thrombosis and Thrombolysis|November 24, 2021
Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndromeBriana Williams, Joseph J Saseen, Toby Trujillo, et al.
The Journal of Applied Laboratory Medicine|September 30, 2020
A Novel Laboratory Assay to Monitor Unfractionated Heparin Dosing in Patients Taking Apixaban Prior to Hospital AdmissionSydney W Strickland, Surabhi Palkimas, Mary Acker, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 1, 2018
The sample that would not clotSydney W Strickland, Emily Burns, Surabhi Palkimas, et al.
Pharmacotherapy|July 18, 2020
The Relationship between the Initial Anti-factor Xa Measurement and the Duration of Direct Oral Anticoagulant Influence in Patients Transitioning to HeparinMichelle D Plum, John N Hedrick, Rebecca Hockman, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Safety and effectiveness of apixaban compared to warfarin in dialysis patientsDaniel Reed, Surabhi Palkimas, Rebecca Hockman, et al.
Journal of Thrombosis and Thrombolysis|September 16, 2016
Direct oral anticoagulants in hypercoagulable statesPaul R Kunk, Jacqueline Brown, Melissa McShane, et al.
The Annals of Pharmacotherapy|January 13, 2022
Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital DischargeLindsay A Courtney, Toby C Trujillo, Joseph J Saseen, et al.
Journal of Thrombosis and Thrombolysis|January 6, 2020
Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experienceThuy Tran, Justin Arnall, Donald C Moore, et al.
Seminars in Thoracic and Cardiovascular Surgery|November 19, 2018
Heparin-Induced Thrombocytopenia and Cardiac SurgeryJigna Solanki, Sundeep Shenoy, Emily Downs, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|September 23, 2021
Safety and Efficacy of Direct Oral Anticoagulants in Patients With Moderate to Severe CirrhosisMildred Oldham, Surabhi Palkimas, Amanda Hedrick
Journal of Thrombosis and Thrombolysis|November 24, 2021
Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndromeBriana Williams, Joseph J Saseen, Toby Trujillo, et al.
The Journal of Applied Laboratory Medicine|September 30, 2020
A Novel Laboratory Assay to Monitor Unfractionated Heparin Dosing in Patients Taking Apixaban Prior to Hospital AdmissionSydney W Strickland, Surabhi Palkimas, Mary Acker, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 1, 2018
The sample that would not clotSydney W Strickland, Emily Burns, Surabhi Palkimas, et al.
Pharmacotherapy|July 18, 2020
The Relationship between the Initial Anti-factor Xa Measurement and the Duration of Direct Oral Anticoagulant Influence in Patients Transitioning to HeparinMichelle D Plum, John N Hedrick, Rebecca Hockman, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Safety and effectiveness of apixaban compared to warfarin in dialysis patientsDaniel Reed, Surabhi Palkimas, Rebecca Hockman, et al.
Journal of Thrombosis and Thrombolysis|September 16, 2016
Direct oral anticoagulants in hypercoagulable statesPaul R Kunk, Jacqueline Brown, Melissa McShane, et al.
The Annals of Pharmacotherapy|January 13, 2022
Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital DischargeLindsay A Courtney, Toby C Trujillo, Joseph J Saseen, et al.
Journal of Thrombosis and Thrombolysis|January 6, 2020
Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experienceThuy Tran, Justin Arnall, Donald C Moore, et al.
Seminars in Thoracic and Cardiovascular Surgery|November 19, 2018
Heparin-Induced Thrombocytopenia and Cardiac SurgeryJigna Solanki, Sundeep Shenoy, Emily Downs, et al.
Pageof 2